News, A to Z Feature 03/04/2025 A to Z: Drugs in Highlight: R is for REXULTI® This series continues to explore the fascinating world of pharmaceuticals. Next up is R is for REXULTI® (from Otsuka Pharmaceutical), also sold under the brand name RXULTI®, It is an antipsychotic medicine used to treat schizophrenia in adults. It is also used as an adjunctive therapy for the treatment of major depressive disorder.
Events, News, Team news 01/04/2025 Webinar: Why does Intellectual Property matter to your business? Join Intellectual Property (IP) specialist Secerna for an insightful webinar: "Why Does Intellectual Property Matter to Your Business?". Delivered by Patent Attorney Melvyn Ansell, this session will equip you with the knowledge to leverage intellectual property (IP) for a real competitive advantage, attract investors, and drive long-term business growth.
News, A to Z Feature 27/03/2025 A to Z: Drugs in Highlight: Q is for QUVIVIQ® This series continues to explore the fascinating world of pharmaceuticals. Next up is QUVIVIQ® (from Idorsia Pharamceuticals) is a medicine for treating adults with insomnia (difficulty falling asleep or staying asleep).
News 24/03/2025 Trade mark 'genericide': the double-edged sword of success Success can be a double-edged sword. Reputation is what all brands strive for, but this can come at a price, and brand owners need to take steps to appropriately ringfence this reputation. If a brand owner does not take the appropriate steps, including protecting and enforcing their trade mark rights, there is a risk of those marks becoming unprotectable generic terms (also known as genericide), subsequently losing their trade mark significance.
News, A to Z Feature 19/03/2025 A to Z: Drugs in Highlight: P is for PAXLOVID® This series continues to explore the fascinating world of pharmaceuticals. Next up is PAXLOVID® an oral antiviral medication developed by Pfizer to treat mild-to-moderate COVID-19 in adults who are at high risk of progressing to severe illness.
News, Team news, Careers 19/03/2025 Join Our Growing Team: Part-Qualified Patent Attorney, Physics & Engineering Are you a Part-Qualified Patent Attorney looking to take your career to the next level? Secerna LLP is excited to announce an exceptional opportunity to join our dynamic Physics and Engineering team. We're seeking a talented and ambitious individual to build upon their existing patent experience in a supportive and collaborative environment, working at the forefront of technological innovation.
Industry news, News 18/03/2025 Global IP Filings Show Strengthening: WIPO Report Signals Innovation Growth A year of economic uncertainty appears to have given way to renewed confidence in the world of intellectual property, according to figures released today by the World Intellectual Property Organization (WIPO). After a dip in 2023, the organisation’s key registries have seen a marked uptick in patent, trade mark, and design applications, suggesting that global innovation is once again on the rise.
News, A to Z Feature 13/03/2025 A to Z: Drugs in Highlight: O is for OZEMPIC® This series continues to explore the fascinating world of pharmaceuticals. Next up is MAVIRET® (from AbbVie), also sold under the brand name MAVYRET®, uses a combination of glecaprevir and pibrentasvir for the treatment of chronic hepatitis C infection.
Industry news, News 10/03/2025 Unlocking Innovation: The Latest on the UK Patent Box Scheme At Secerna, we understand the critical role intellectual property (IP) plays in fostering a robust innovation ecosystem. Government incentive programs like the Patent Box offer significant tax advantages specifically designed to encourage research and development (R&D) activities. This article provides a comprehensive overview of the latest developments in the Patent Box scheme and its potential benefits for your business, helping you unlock tax savings and fuel a culture of innovation.
